154 related articles for article (PubMed ID: 17627174)
21. Diagnosis and management of dysfunctional voiding.
Feldman AS; Bauer SB
Curr Opin Pediatr; 2006 Apr; 18(2):139-47. PubMed ID: 16601493
[TBL] [Abstract][Full Text] [Related]
22. Vesico ureteric reflux and urinary tract infections in children.
Woodward A
Aust Fam Physician; 1998 Dec; 27(12):1095-7. PubMed ID: 9919731
[TBL] [Abstract][Full Text] [Related]
23. Initial trial of timed voiding is warranted for all children with daytime incontinence.
Allen HA; Austin JC; Boyt MA; Hawtrey CE; Cooper CS
Urology; 2007 May; 69(5):962-5. PubMed ID: 17482943
[TBL] [Abstract][Full Text] [Related]
24. Prospective evaluation of inpatient and outpatient bladder training in children with functional urinary incontinence.
Heilenkötter K; Bachmann C; Janhsen E; Stauber T; Lax H; Petermann F; Bachmann H
Urology; 2006 Jan; 67(1):176-80. PubMed ID: 16413359
[TBL] [Abstract][Full Text] [Related]
25. Dysfunctional Voiding and Incontinence Scoring System for Children and Adolescents: A Tool to Predict Clinical Course and Outcome.
Sommer-Joergensen V; Sarcevic J; Haecker FM; Holland-Cunz S; Gros SJ; Frech-Dörfler M
Eur J Pediatr Surg; 2022 Oct; 32(5):429-434. PubMed ID: 35114717
[TBL] [Abstract][Full Text] [Related]
26. The office management of recurrent urinary tract infection and vesicoureteral reflux in children.
Shapiro E; Elder JS
Urol Clin North Am; 1998 Nov; 25(4):725-34, x. PubMed ID: 10026778
[TBL] [Abstract][Full Text] [Related]
27. Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy.
Cheng CH; Tsai MH; Huang YC; Su LH; Tsau YK; Lin CJ; Chiu CH; Lin TY
Pediatrics; 2008 Dec; 122(6):1212-7. PubMed ID: 19047236
[TBL] [Abstract][Full Text] [Related]
28. Effect of biofeedback treatment on spinning top urethra in children with voiding dysfunction.
Kibar Y; Demir E; Irkilata C; Ors O; Gok F; Dayanc M
Urology; 2007 Oct; 70(4):781-4; discussion 784-5. PubMed ID: 17991555
[TBL] [Abstract][Full Text] [Related]
29. The use of botulinum toxin A injection for the management of external sphincter dyssynergia in neurologically normal children.
Franco I; Landau-Dyer L; Isom-Batz G; Collett T; Reda EF
J Urol; 2007 Oct; 178(4 Pt 2):1775-9; discussion 1779-80. PubMed ID: 17707430
[TBL] [Abstract][Full Text] [Related]
30. Spina bifida occulta: is it a predictor of underlying spinal cord abnormality in patients with lower urinary tract dysfunction?
Nejat F; Radmanesh F; Ansari S; Tajik P; Kajbafzadeh A; El Khashab M
J Neurosurg Pediatr; 2008 Feb; 1(2):114-7. PubMed ID: 18352778
[TBL] [Abstract][Full Text] [Related]
31. Biofeedback training for lower urinary tract symptoms: factors affecting efficacy.
Drzewiecki BA; Kelly PR; Marinaccio B; Borer JG; Estrada CR; Lee RS; Bauer SB
J Urol; 2009 Oct; 182(4 Suppl):2050-5. PubMed ID: 19695584
[TBL] [Abstract][Full Text] [Related]
32. Botulinum toxin type A in combination with standard urotherapy for children with dysfunctional voiding.
Petronijevic V; Lazovic M; Vlajkovic M; Slavkovic A; Golubovic E; Miljkovic P
J Urol; 2007 Dec; 178(6):2599-602; discussion 2602-3. PubMed ID: 17945299
[TBL] [Abstract][Full Text] [Related]
33. Urge incontinence and voiding postponement in children: somatic and psychosocial factors.
Lettgen B; von Gontard A; Olbing H; Heiken-Löwenau C; Gaebel E; Schmitz I
Acta Paediatr; 2002; 91(9):978-84; discussion 895-6. PubMed ID: 12412876
[TBL] [Abstract][Full Text] [Related]
34. EAU-ESPU guidelines recommendations for daytime lower urinary tract conditions in children.
Tekgul S; Stein R; Bogaert G; Undre S; Nijman RJM; Quaedackers J; 't Hoen L; Kocvara R; Silay MS; Radmayr C; Dogan HS
Eur J Pediatr; 2020 Jul; 179(7):1069-1077. PubMed ID: 32472266
[TBL] [Abstract][Full Text] [Related]
35. Renal scarring and urinary tract infection after successful endoscopic correction of vesicoureteral reflux.
Chertin B; Natsheh A; Fridmans A; Shenfeld OZ; Farkas A
J Urol; 2009 Oct; 182(4 Suppl):1703-6. PubMed ID: 19692032
[TBL] [Abstract][Full Text] [Related]
36. The effect of dysfunctional voiding on the costs of treating vesicoureteral reflux: a computer model.
Benoit RM; Wise BV; Naslund MJ; Mathews R; Docimo SG
J Urol; 2002 Nov; 168(5):2173-6; discussion 2176. PubMed ID: 12394753
[TBL] [Abstract][Full Text] [Related]
37. Recurrent urinary tract infections in children: a logical approach to diagnosis, treatment, & long-term management.
Collins TR; deVries CR
Compr Ther; 1997 Jan; 23(1):44-8. PubMed ID: 9067082
[No Abstract] [Full Text] [Related]
38. Clinical differences in daytime wetting subtypes: urge incontinence and postponed voiding.
Kuhn S; Natale N; Siemer S; Stoeckle M; von Gontard A
J Urol; 2009 Oct; 182(4 Suppl):1967-72. PubMed ID: 19695641
[TBL] [Abstract][Full Text] [Related]
39. Predicting early recurrent urinary tract infection in pretoilet trained children with vesicoureteral reflux.
Yamazaki Y; Shiroyanagi Y; Matsuno D; Nishi M
J Urol; 2009 Oct; 182(4 Suppl):1699-702. PubMed ID: 19692080
[TBL] [Abstract][Full Text] [Related]
40. Microalbuminuria in children with vesicoureteral reflux.
Basic J; Golubovic E; Miljkovic P; Bjelakovic G; Cvetkovic T; Milosevic V
Ren Fail; 2008; 30(6):639-43. PubMed ID: 18661415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
